What to expect as US weighs COVID shots for younger kids
By LAURAN NEERGAARD AP Medical Writer It could take U.S. regulators a few weeks to decide whether to clear COVID-19 vaccines for children ages 5 to 11. First, advisers to the Food and Drug Administration will publicly deliberate Pfizer’s evidence on Oct. 26. That sets the stage for the agency to declare if the shots
Continue Reading